Browsing Tag
Jacobio Pharma
2 posts
Jacobio Pharma secures $2bn global licensing agreement with AstraZeneca for JAB-23E73
Jacobio Pharma’s $2B global licensing deal with AstraZeneca could reshape KRAS inhibitor strategy in oncology. Read the full breakdown of the partnership now.
December 22, 2025
Jacobio Pharma doses first patient with Aurora A inhibitor JAB-2485 in phase 1/2a trial
Jacobio Pharma said that it has completed the first patient dosage of Aurora A inhibitor JAB-2485, its in-house…
January 8, 2023